Valerie Julia

Company: Galderma

Job title: Head of Research & Early Development

Seminars:

Investigating IL-31 as a Novel Candidate Pathway for Prurigo Nodularis (PN) 12:05 pm

Exploring the scientific rationale for investigating IL-31 in PN Unravelling key findings in phase 2 clinical data Elucidating the mechanism of action of nemolizumab in PN using a multi-omics approachRead more

day: Day One